Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Conoce los avances en el tratamiento de la miastenia gravis, enfocándote en mejorar la calidad de vida de los pacientes y las limitaciones de la terapia desde la perspectiva de expertos.

Episodios recientes

Mostrar más

Nov 19, 2024

Wrap Up

2 mins

Nov 19, 2024

Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

3 mins

Nov 19, 2024

Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

3 mins

Nov 19, 2024

Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

3 mins

Nov 19, 2024

Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT

3 mins